Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2021
DOI: 10.1007/s10593-021-02867-w
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of 2-triazolylpurine Phosphonates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…The major component was found to be partially reduced 2-triazolylpyrido [3,2-d]pyrimidine 7 (Scheme 6). We [36][37][38] and others [39] have previously observed that azido groups can be selectively reduced to their respective amino derivatives by Cu(I), which is generated by the CuSO4/ascorbate system.…”
Section: Synthesismentioning
confidence: 96%
“…The major component was found to be partially reduced 2-triazolylpyrido [3,2-d]pyrimidine 7 (Scheme 6). We [36][37][38] and others [39] have previously observed that azido groups can be selectively reduced to their respective amino derivatives by Cu(I), which is generated by the CuSO4/ascorbate system.…”
Section: Synthesismentioning
confidence: 96%
“…Then, the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction provides the target product IV (Scheme 1, pathway A) [59][60][61]. Pathway B is designed on the basis of our group investigations on the synthesis of 2,6-bistriazolylpurine derivatives and their application in reactions with N-, S-and P-nucleophiles making use of regioselective S N Ar reactions at C(6) (V→VI→IV, Scheme 1) [11,14,62,63,77,78]. The main advantage of pathway B is a straightforward access to 2,6-diazidopurines V and 2,6-bistriazolylpurines VI due to excellent nucleophilic properties of the azide ion and wellestablished CuAAC reaction.…”
Section: Introductionmentioning
confidence: 99%